# IAC Inc. (IACI) — Financial Analysis

**Exchange:** NASDAQ  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-27  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/IACI/thesis · /stocks/IACI/memo

## Financial Snapshot

---
source: coverage-next-full
ticker: IACI
company: IAC Inc.
step: 04
title: Financial Quality & Adversarial Sweep
created: 2026-05-27
---

### Step 04 — Financial Quality: IAC Inc. (IACI)

#### Key Findings
- IAC's GAAP financials are significantly distorted by MGM fair value marks (up to ±$649M annually) and goodwill impairments, making net income largely meaningless as an operating metric. **The right operating lens is Adjusted EBITDA and free cash flow.**
- Stock-based compensation is elevated ($258M in FY2025) relative to Adj EBITDA ($273M net of corporate) — meaning "true" cash-equivalent earnings are materially lower than EBITDA suggests.
- Free cash flow has been strong ($1.0B in FY2025) but reflects both continuing and discontinued operations (Angi ran through Q1 2025) — normalizing to People Inc. only yields lower FCF.
- **Adversarial Sweep:** IAC has faced multiple significant legal/litigation exposures, including a $19M loss on a disputed real estate gain transaction (2025), ongoing litigation at The Daily Beast/legacy IAC entities, and a $207M Care.com goodwill impairment. No securities fraud investigations, short-seller attacks, or going-concern issues identified.

#### Implications for Thesis and Valuation
The financial quality review is **mixed**: FCF is genuinely strong, EBITDA is growing and of good quality at the People Inc. Digital level, but the corporate level distortions (SBC, impairments, fair value marks, legacy litigation) create accounting noise that obscures operating health. Investors must anchor to People Inc. segment-level Adjusted EBITDA ($357M in FY2025) and apply appropriate SOTP multiples rather than consolidated GAAP metrics.

#### Objective
Assess accounting quality, identify statement adjustments needed, review adversarial findings, and establish the "clean" earnings power of IAC.

#### Narrative Analysis

##### Earnings Quality Assessment

**GAAP Income Statement Distortions:**

1. **MGM Fair Value Mark** (largest distortion): IAC uses the fair value option for its MGM equity stake, meaning the entire unrealized gain or loss on ~$2.8B of MGM shares flows through the income statement each quarter. In FY2025, this was a +$119M benefit; in FY2024, it was a -$649M charge [S2]. This item has nothing to do with IAC's operating performance and should be excluded entirely from operating analysis.

2. **Goodwill Impairments**: $207M in FY2025 (Care.com impairment) and $9M in FY2024. These are non-cash charges reflecting write-downs of overpaid acquisitions. Care.com was acquired for ~$500M in 2020 and is being sold for $296M — confirming the impairment was justified. Analysts and management add back impairments to Adjusted EBITDA [S2].

3. **Amortization of Intangibles**: $93M in FY2025, declining from $141M in FY2024 and $288M in FY2023. This is primarily from the Meredith acquisition (2021). Amortization is non-cash and will continue declining as intangibles are fully amortized.

4. **Stock-Based Compensation**: $258M in FY2025 (includes $49.8M RSU reversal from Joey Levin departure). Normalized SBC is ~$307M [S4]. At ~$3.30-4.00 per share annually, SBC represents real economic dilution even if non-cash.

5. **Discontinued Operations**: Angi was consolidated through Q1 2025; all prior periods restated to show Angi as discontinued. Care.com classified as discontinued from Q1 2026. This creates comparability challenges across periods.

##### Adjusted EBITDA Reconciliation (FY2025, $M)

| Item | Amount |
|------|--------|
| GAAP Operating Loss (continuing ops) | ($97M) |
| + SBC | +$258M |
| + D&A | +$105M |
| + Goodwill/Intangible Impairments | +$207M |
| **= Segment Adj EBITDA** | **$386M** (approx, + some rounding) |
| - Corporate Overhead | ($113M) |
| **Net Adj EBITDA** | **$273M** |

*Note: Corporate overhead is the catch-all for HQ costs, Diller/Halpin compensation, legal, and public company costs.*

##### Free Cash Flow Quality
| Year | FCF ($M) | Notes |
|------|----------|-------|
| FY2023 | $829M | Includes Angi/Dotdash Meredith |
| FY2024 | $882M | Includes Angi (full year) |
| FY2025 | $1,024M | Includes Angi (Q1 only before spinoff); includes Care.com |
| FY2026E | $400-600M est. | People Inc. + Emerging only; significant revenue reduction |

FCF appears strong historically, but the FY2026 clean run rate will be meaningfully lower once Angi and Care.com are fully removed. A rough estimate: People Inc. EBITDA ($357M) - $120M interest - $57M capex - ~$150M taxes/working capital = ~$400-450M FCF from ongoing operations. This still represents an attractive ~12-14% FCF yield on market cap.

##### CapEx and Maintenance Investment
CapEx has been falling sharply: $93M (FY2023) → $57M (FY2025) [S4]. This reflects both Angi spinoff (which had meaningful capex) and cost discipline at People Inc. Digital. Digital media is relatively capital-light; the declining CapEx is appropriate.

---

#### Adversarial Research Sweep

*Note: No earnings call transcripts loaded. Analysis based on filings, press releases, and web search.*

##### Identified Risks and Adversarial Items

**1. Google Non-Renewal of Services Agreement (High Impact)**
- December 10, 2025: Google gave non-renewal notice for the IAC Search Services Agreement
- This agreement was generating 99% of Search segment revenue ($213M in FY2025, $388M in FY2024)
- The agreement expired March 31, 2026 — this risk materialized and is fully embedded in FY2026 estimates
- The question is whether this signals broader Google deterioration of the IAC relationship or was specific to the declining Search business

**2. Google AI Overviews Impact on People Inc. (High Impact, Ongoing)**
- Not just Search — Google AI Overviews are directly reducing People Inc. Core Sessions
- FY2025: -5% Core Sessions; Q1 2026: further acceleration expected
- This is an industry-wide risk, not IAC-specific, but IAC's content verticals (health, home, food, finance) are particularly susceptible to AI-answered queries
- Management acknowledges this explicitly and guides for continued headwind

**3. Real Estate Litigation ($19M Loss)**
- In FY2025, IAC recorded a $19M loss related to "allocation of a disputed gain on a real estate transaction" [S2]
- Details not fully described in filings; appears to be a dispute over proceeds from leased office space early surrender
- Modest but noteworthy — legal complexity around corporate real estate actions

**4. Legacy Litigation (The Daily Beast)**
- Q3 FY2025: $19.4M in legal fees and settlement expenses for litigation related to "a legacy business" — likely The Daily Beast or another media entity
- Contributed to Emerging & Other Adj EBITDA loss improvement year-over-year (but still negative)

**5. Care.com Goodwill Impairment ($207M)**
- IAC acquired Care.com for ~$500M in 2020 and recorded impairment charges totaling $207M in FY2025
- Sold in March 2026 for $296M — confirming significant value destruction from the original acquisition
- This is a retrospective capital allocation failure but does not affect forward thesis

**6. CEO Transition Risk**
- Joey Levin departed with $15.2M separation package in early 2025
- Christopher Halpin (former NFL COO/CFO) is new CEO — limited track record in internet media
- Diller's continued presence as Chairman and Senior Executive provides strategic continuity

**7. People Inc. UK Pension Liability**
- People Inc. maintains a legacy UK defined benefit pension plan (IPC Plan) with ~$250M projected benefit obligation
- Not immediately cash-impactful but represents contingent liability if investment returns underperform

**No Evidence Found Of:**
- Securities fraud investigations or SEC enforcement actions
- Significant short-seller reports with material allegations
- Accounting irregularities or restatements
- Going concern issues
- Related-party self-dealing beyond disclosed governance arrangements

#### Evidence and Sources
- 10-K FY2025 (Note 14, 15 for litigation; MD&A for all items)
- StockAnalysis cash flow data
- Web search for short-seller reports (none found)

#### Assumption Register Updates
- A11: SBC = $258M in FY2025 (includes $49.8M RSU reversal) [FACT]

#### Tables and Calculations

##### Key Statement Quality Metrics

| Metric | FY2025 | FY2024 | FY2023 | Assessment |
|--------|--------|--------|--------|------------|
| Cash Conversion (OCF/Net Income) | NM (loss) | NM (loss) | 71% | N/A — use Adj metrics |
| Adj EBITDA Conversion (FCF/EBITDA) | 265% (FCF/$386M) | 274% | 266% | Elevated — Angi included |
| SBC % Revenue | 10.8% | 10.2% | 5.3% | High; declining normalize |
| Maintenance CapEx/Revenue | 2.4% | 1.9% | 1.5% | Low — capital-light model |
| D&A/Revenue | 4.4% | 6.2% | 2.5% | Declining intangible amort |
| Net Debt/Adj EBITDA | 1.7x | 8.7x (incl. MGM FV adjustment) | 1.9x | Manageable at seg. level |

##### GAAP vs. Adjusted EBITDA Bridge (FY2025, $M)

| Item | FY2025 |
|------|--------|
| GAAP Net Loss (cont. ops) | ($104M) |
| Add: Income taxes | $35M |
| Add: Interest expense | $120M |
| Add: Other income, net | ($16M) |
| Add: MGM unrealized (gain) | ($119M) |
| Add: D&A | $131M |
| Add: SBC | $258M |
| Add: Impairments | $207M |
| **≈ Adjusted EBITDA** | **~$512M gross** |
| Less: Corporate EBITDA loss allocated above | ($113M) |
| Less: Segment-level items not in EBITDA | Various |
| **Segment Adj EBITDA** | **$386M** |

#### Open Questions and Data Gaps
1. Exact breakdown of D&A by segment (affects per-segment FCF calculation)
2. People Inc. UK pension liability cash funding requirements over next 5 years
3. Tax basis in MGM shares (relevant for computing after-tax proceeds on hypothetical sale)
4. Normalized SBC level without the $49.8M Levin RSU reversal benefit

#### Source Index

| Source Tag | Document | Section | Date | Notes |
|-----------|----------|---------|------|-------|
| [S1] | 10-K FY2025 | Item 1 — Risk factors | 2026-02-20 | Adversarial risks |
| [S2] | 10-K FY2025 | MD&A — Adj EBITDA reconciliation, Other income | 2026-02-20 | EBITDA bridge, MGM FV |
| [S3] | 10-K FY2025 | Notes 6, 15 | 2026-02-20 | Debt, litigation |
| [S4] | StockAnalysis.com | Cash flow, income | 2026-05-27 | SBC, FCF data |
| [S5] | Web search | Short seller, litigation | 2026-05-27 | Adversarial sweep |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/IACI/fundamental

## Navigation

- Overview: /stocks/IACI
- Financials (this page): /stocks/IACI/financials
- Thesis: /stocks/IACI/thesis
- Investment Memo: /stocks/IACI/memo
- Coverage universe: /stocks